Auriga

Auriga has published a research report on Spectrum Pharmaceuticals (NASDAQ: SPPI) commenting on the generic drug application for Fusilev. In the report, Auriga writes, "A company filed a generic drug application that challenges the Fusilev orange book listed patent. The market reacted negatively...

Auriga has published a research report on MEMC Electronic Materials (NYSE: WFR) commenting on the company's $700 million restructuring plan. In the report, Auriga writes, "In a fit of rare decisiveness that was absent for the past two years, MEMC finally woke up from its slumber to gain cost/...

Auriga has published a research report on First Solar (NASDAQ: FSLR) commenting on the company's s announcement on selling Topaz to Berkshire Hathaway (NYSE: BRK.A). In the report, Auriga writes, "First Solar's announcement this morning that it sold the 550MW Topaz Solar Farm to MidAmerican Energy...

Auriga has published a research report on Western Digital Corporation (NYSE: WDC) after the company provided a business update showing parallels to Auriga's forecast on WDC. In the report, Auriga writes, "WD provided an update on the December quarter, with highlights being guidance to revenue of $...

Auriga has published a research report on OCZ Technology Group (NASDAQ: OCZ) after the company pre-announced its 2Q12 earnings. In the report, Auriga writes, "OCZ pre-announced strong revenue for its F2Q12 (November) quarter this morning, but offered no insight into margins or EPS. Based on the...

Auriga has published a research report on Western Digital Corporation (NYSE: WDC) and expects the company's EPS outlook to prove positive trends. In the report, Auriga writes, "We are pro-actively increasing our pro-forma EPS estimates well above both WD's latest stated guidance and Street...

Auriga maintains its Buy rating and $10 target price on Affymax, Inc. (NASDAQ: AFFY) ahead of the upcoming ODAC review of the peginesatide NDA on December 7. Auriga comments, “Panels and FDA events are not for the faint of heart, and it goes without saying AFFY shares will be volatile over the...

In a research note, Auriga reiterates its Buy rating and $68 target on Lululemon Athletica Inc. (NASDAQ: LULU) as upside from strong comps it expected on the upcoming 3Q earnings. According to Auriga, “As noted in a report published in early November, we believe LULU's fall offering sold through...

Auriga maintains its Buy rating and $20 target on Omnicell, Inc. (NASDAQ: OMCL) as the company's entrance into China hold potential. Auriga says, “We are reiterating our BUY rating on Omnicell on the heels of its announcement of its first installation in China with Peking Union Medical College...

A report from Auriga reiterates its Sell rating and $2 price target on Yingli Green Energy Holding Co. (NYSE: YGE). The report states, “The company's polysilicon plant is a white elephant that is set to ramp in 2012 with cost set at $45/kg for 1Q12 and $35/kg for 2H12 compared to current spot...

A report from Auriga reiterates its Sell rating and $1 price target on Suntech Power Holdings (NYSE: STP). The report states, “Cumulatively, Suntech is on track for ~$300M in GAAP earnings (2.7% net margin) from 2006 to 2011 on ~$11.5B in sales. With goodwill impairment on the cards those meager...

Trina Solar (NYSE: TSL) reported in-line 3Q revenues that came in slightly below consensus estimates ($482M vs. $519M, respectively) due largely in part to difficulty in financing projects in the solar industry. While Trina Solar attempted to cut costs during its 3Q, gross margins fell to 10.8%,...

A report from Auriga reiterates its Buy rating and $32 price target on Hewlett-Packard (NYSE: HPQ). The report states, “HP reported mixed F4Q11 results, with stronger than expected revenue offset by soft gross margin, but pro-forma EPS bailed out by more thrown into the “nonGAAP” OpEx bucket....

A report from Auriga downgrades its rating from Hold to Sell and lowers its price target from $8 to $3.50 on Trina Solar (NYSE: TSL). The report states, “Despite being a c-Si leader, Trina Solar's pathway to 2013 will surely be marked by losses as solar PV industry is hit with suicidal pricing....

A report from Auriga upgrades its rating to Buy and raises its price target from $15 to $20 on Collective Brands (NYSE: PSS). The report states, “Our upgrade to a Buy rating is based on our belief that profitability for PSS likely reached bottom during Q3. Comps fell 3.7% due to a slow start to...